Key result
This prospective observational study protocol has enrolled 70 infants with Down's syndrome to assess myocardial function and pulmonary haemodynamics over their first two years of life.
Why the study?
The impact of Down's syndrome, congenital heart disease, and associated pulmonary hypertension on myocardial function during transition and over the first 2 years of age is not well defined.
How do myocardial function and pulmonary haemodynamics evolve in infants with Down's syndrome over the first two years of life compared to healthy controls?
Observational (n=70)
Yes
How do myocardial function and pulmonary haemodynamics evolve in infants with Down's syndrome over the first two years of life compared to healthy controls?
This study protocol describes a prospective observational study to longitudinally assess cardiac function and pulmonary hemodynamics in infants with Down's syndrome using novel echocardiography.
Background: Down’s syndrome (DS) is the most common chromosomal abnormality globally. Ireland has one of the highest rates of DS in the western world with an incidence of 1:444 live births. Congenital heart disease (CHD) and pulmonary hypertension (PH) are the commonest morbidities affecting the cardiovascular system in DS. PH is associated with significant morbidity and an increase risk of mortality. The impact of the diagnosis of DS, the presence of CHD and the associated PH on myocardial function during transition and over the first 2 years of age in this population is not well defined and warrants further study. In particular, serial measurements of pulmonary pressures in this population over the first week of age are lacking. This study aims to characterise myocardial function and pulmonary haemodynamics in infants with Down syndrome during the transitional period (over the first week of age) and throughout the first two years of age. Methods: A prospective, observational study utilising novel echocardiography techniques to assess myocardial function and pulmonary haemodynamics over the first two years of age in infants with Down Syndrome. A population of healthy infants without CHD or a diagnosis of DS will be recruited as controls. This study will be conducted across the three Dublin maternity units. Discussion: In total, 70 babies with DS have been enrolled into this study with 292 echocardiograms performed to date. Further evaluation of cardiac performance in DS infants with and without CHD may yield more insight into the pathophysiology of cardiac dysfunction and pulmonary hypertension that are recognised features in these patients. This could aid in our ability to monitor and treat patients, as well as improve our ability to predict outcomes.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2020) conducted an observational in Down's syndrome (n=70). Down's syndrome vs. Healthy infants without congenital heart disease or Down's syndrome was evaluated on Myocardial function and pulmonary haemodynamics. This prospective observational study protocol has enrolled 70 infants with Down's syndrome to assess myocardial function and pulmonary haemodynamics over their first two years of life.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: